• Gao, F., Bian, L.L., Chen, L., Zhou, Y.P., Li, G.F., Mao, Q.Y., He, Q., Wu, X., Yao, S.S., Yang, X.M.,Liang, Z.L., 2021. A cross-sectional seroepidemiology study of seven major enteroviruses causing HFMD in Guangdong, China. J Infect, 83, 119-145.

  • Geng, Y., Zhang, L., 2022. Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China. J Infect, 84, e13-e15.

  • Huang, W.C., Huang, L.M., Kao, C.L., Lu, C.Y., Shao, P.L., Cheng, A.L., Fan, T.Y., Chi, H.,Chang, L.Y., 2012. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect, 45, 96-101.

  • Li, P., Chen, Y., Tang, A., Gao, F., Yan, J.B., 2021. Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis. Arch Public Health, 79, 166.

  • Shen, L., Sun, M., Song, S., Hu, Q., Wang, N., Ou, G., Guo, Z., Du, J., Shao, Z., Bai, Y., Liu, K., 2022. The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China. J Med Virol, 94, 3121-3132.

  • Song D., 2020. Serological Survey of Hand, Foot and Mouth Disease among Healthy People in Hebei District, Tianjin City, 2016-2019 Year. Medical Information, 33, 147-149. (In Chinese).

  • Wang, J., Liu, J., Fang, F., Wu, J., Ji, T., Yang, Y., Liu, L., Li, C., Zhang, W., Zhang, X., Teng, Z., 2022. Genomic surveillance of coxsackievirus A10 reveals genetic features and recent appearance of genogroup D in Shanghai, China, 2016-2020. Virol Sin, 37, 177-186.

  • Wang, J., Teng, Z., Cui, X., Li, C., Pan, H., Zheng, Y., Mao, S., Yang, Y., Wu, L., Guo, X., Zhang, X., Zhu, Y., 2018. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016. Emerg Microbes Infect, 7, 8.

  • Wang, J.X., Zhu, S.L., Wang, J., Lin, Y., Pei, Y.W., Sun, D.P., Zhang, Y., Wang, X.J., Xu, W.B., Ding, S.J., 2016. Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China. PLoS One, 11, e0162373.

  • Yang, B., Liu, F., Liao, Q., Wu, P., Chang, Z., Huang, J., Long, L., Luo, L., Li, Y., Leung, G.M., Cowling, B.J., Yu, H., 2017. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill, 22.

  • Zhou, Y., Van Tan, L., Luo, K., Liao, Q., Wang, L., Qiu, Q., Zou, G., Liu, P., Anh, N.T., Hong, N.T.T., He, M., Wei, X., Yu, S., Lam, T.T., Cui, J., Van Doorn, H.R.,Yu, H., 2021. Genetic Variation of Multiple Serotypes of Enteroviruses Associated with Hand, Foot and Mouth Disease in Southern China. Virol Sin, 36, 61-74.

  • Zhou, Y., Zhou, J., Yang, J., Qiu, Q., Wang, L., Yang, J., Li, Y., Liang, L., Cui, P., Cheng, Y., Zheng, W., Shi, H., Gong, H., Wang, K., Zhou, C., Chu, J.J.H., Yu, H., 2022. Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019. J Immunol, 209, 280-287.

  • Zhu, F.C., Meng, F.Y., Li, J.X., Li, X.L., Mao, Q.Y., Tao, H., Zhang, Y.T., Yao, X., Chu, K., Chen, Q.H., Hu, Y.M., Wu, X., Liu, P., Zhu, L.Y., Gao, F., Jin, H., Chen, Y.J., Dong, Y.Y., Liang, Y.C., Shi, N.M., Ge, H.M., Liu, L., Chen, S.G., Ai, X., Zhang, Z.Y., Ji, Y.G., Luo, F.J., Chen, X.Q., Zhang, Y., Zhu, L.W., Liang, Z.L., Shen, X.L., 2013. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 381, 2024-2032.

  • Zhu, R., Cheng, T., Yin, Z., Liu, D., Xu, L., Li, Y., Wang, W., Liu, J., Que, Y., Ye, X., Tang, Q., Zhao, Q., Ge, S., He, S., Xia, N., 2018. Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population. Emerg Microbes Infect, 7, 2.